New drug tested to fight daytime sleepiness
NCT ID NCT07082829
Summary
This is an early-stage study to test the safety of a new drug called ORX142 for people who struggle with excessive daytime sleepiness. Researchers will give the drug to healthy adults, including some who are sleep-deprived, to see how their bodies handle it and if it helps them stay awake. The main goal is to check for side effects and understand how the drug works in the body before testing it in people with medical conditions.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EXCESSIVE DAYTIME SLEEPINESS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Site #1
RECRUITINGLincoln, Nebraska, 68502, United States
-
Site #2
RECRUITINGEatontown, New Jersey, 07724, United States
-
Site #3
RECRUITINGNew York, New York, 10019, United States
Conditions
Explore the condition pages connected to this study.